Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
M
Medico Remedies Ltd
Score 63/100• Decent
Medico Remedies Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks. Caution is advised for investors.
Company’s Health80/100
Valuation 20/100 · PB 6.7017
Technical Avoid
1M -0.66% 6M -8.389% 1Y -12.61%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#151
View details ➜
M
Medico Intercontinental Ltd
Score 63/100• Decent
Medico Intercontinental Ltd shows potential but faces challenges in growth and profitability metrics.
Company’s Health64/100
Valuation 100/100 · PB 0.7145
Technical Avoid
1M -12.83% 6M -8.502% 1Y -27.082%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#152
View details ➜
I
Infinium Pharmachem Ltd
Score 63/100• Decent
Infinium Pharmachem Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health80/100
Valuation 40/100 · PB 3.3092
Technical Avoid
1M 2.148% 6M -12.829% 1Y -18.21%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#153
View details ➜
L
Laxmi Dental Ltd
Score 63/100• Decent
Laxmi Dental Ltd shows potential in a growing sector, but faces significant challenges in profitability and valuation metrics. Caution is advised.
Company’s Health72/100
Valuation 20/100 · PB 8.2746
Technical Avoid
1M -2.571% 6M -18.968% 1Y -42.93%
Confidence100%
Low leverage (D/E)No promoter pledge
#154
View details ➜
A
Asston Pharmaceuticals Ltd
Score 63/100• Decent
Asston Pharmaceuticals Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised due to execution risks.
Company’s Health91/100
Valuation 20/100 · PB 6.4132
Technical Avoid
1M -16.111% 6M -33.493% 1Y -33.493%
Confidence100%
No promoter pledgeHealthy profit margins
#155
View details ➜
N
Novateor Research Laboratories Ltd
Score 63/100• Decent
The stock shows some potential but faces significant risks and challenges that may hinder growth.
Company’s Health63/100
Valuation 80/100 · PB 1.4929
Technical Avoid
1M 13.043% 6M -37.947% 1Y -50.287%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#156
View details ➜
B
Bharat Immunologicals and Biologicals Corporation Ltd
Score 63/100• Decent
Bharat Immunologicals shows potential but faces significant challenges in growth and profitability metrics.
Company’s Health49/100
Valuation 80/100 · PB 1.0008
Technical Avoid
1M -0.097% 6M -10.352% 1Y -16.048%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#157
View details ➜
B
Balaxi Pharmaceuticals Ltd
Score 63/100• Decent
Balaxi Pharmaceuticals has potential but faces significant challenges in growth and profitability metrics.
Company’s Health87/100
Valuation 80/100 · PB 1.023
Technical Avoid
1M -4.558% 6M -21.398% 1Y -52.262%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#158
View details ➜
B
Brawn Biotech Ltd
Score 62/100• Decent
Brawn Biotech Ltd shows potential in a growing sector but faces significant challenges in profitability and execution risks.
Company’s Health46/100
Valuation 80/100 · PB 1.8841
Technical Avoid
1M -0.226% 6M 23.826% 1Y 1.491%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#159
View details ➜
V
Veerhealth Care Ltd
Score 58/100• Decent
Veerhealth Care Ltd shows potential in a growing sector, but faces significant challenges in profitability and governance that could hinder future performance.
Company’s Health55/100
Valuation 80/100 · PB 1.611
Technical Avoid
1M -1.863% 6M 34.485% 1Y -10.545%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#160
View details ➜
G
Genomic Valley Biotech Ltd
Score 58/100• Decent
Genomic Valley Biotech Ltd shows potential in a growing sector, but faces significant challenges in profitability and valuation metrics.
Company’s Health45/100
Valuation 60/100 · PB 2.6231
Technical Avoid
1M -6.553% 6M -49.56% 1Y -69.826%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#161
View details ➜
S
Sanjivani Paranteral Ltd
Score 58/100• Decent
Sanjivani Paranteral Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
Company’s Health86/100
Valuation 20/100 · PB 6.4934
Technical Avoid
1M -4.605% 6M -11.001% 1Y -32.732%
Confidence100%
Low leverage (D/E)No promoter pledge
#162
View details ➜
A
Achyut Healthcare Ltd
Score 58/100• Decent
Achyut Healthcare Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
Company’s Health70/100
Valuation 40/100 · PB 4.6434
Technical Avoid
1M -5.673% 6M 64.873% 1Y 17.916%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#163
View details ➜
A
Aakaar Medical Technologies Ltd
Score 58/100• Decent
Aakaar Medical Technologies Ltd shows potential in a growing sector, but faces significant challenges in growth consistency and profitability metrics.
Company’s Health84/100
Valuation 20/100 · PB 5.2507
Technical Avoid
1M 3.571% 6M 20.632% 1Y 20.632%
Confidence100%
No promoter pledgeDecent revenue growth
#164
View details ➜
T
TTK Healthcare Ltd
Score 57/100• Decent
TTK Healthcare Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health80/100
Valuation 80/100 · PB 1.5629
Technical Avoid
1M 1.107% 6M -2.709% 1Y -23.337%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#165
View details ➜
Showing 151 to 165 of 301 (21 Pages)